Abstract
Although anal cancer is rare in the general population, its incidence is unacceptably high in people living with HIV. Among people living with HIV older than 45 years, incidence rates are 100 per 100 000 person years in men who have sex with men (MSM), 37 per 100 000 person years in men who have sex with women (MSW), and 30 per 100 000 person years in women.1 Anal cancer screening has been recommended by several organisations to reduce anal cancer morbidity and mortality.2,3 Screening includes a digital anal rectal exam (DARE) to detect masses associated with cancers and collection of anal swabs for cytology or human papillomavirus.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
